Search hospitals > Wisconsin > Madison
University of Wisconsin
Claim this profileMadison, Wisconsin 53792
Global Leader in Cancer
Global Leader in Recurrence
Conducts research for Breast Cancer
Conducts research for Tumors
Conducts research for Lung Cancer
952 reported clinical trials
127 medical researchers
Summary
University of Wisconsin is a medical facility located in Madison, Wisconsin. This center is recognized for care of Cancer, Recurrence, Breast Cancer, Tumors, Lung Cancer and other specialties. University of Wisconsin is involved with conducting 952 clinical trials across 1,471 conditions. There are 127 research doctors associated with this hospital, such as Kenneth B. De Santes, Nataliya V. Uboha, Kari B. Wisinski, and Ticiana A. Leal.Area of expertise
1Cancer
Global LeaderStage IV
Stage III
HER2 positive
2Recurrence
Global LeaderStage III
Stage I
Stage II
Top PIs
Kenneth B. De SantesUniversity of Wisconsin Carbone Cancer Center6 years of reported clinical research
Expert in Tumors
Expert in Brain Tumor
57 reported clinical trials
104 drugs studied
Nataliya V. UbohaUniversity of Wisconsin Carbone Cancer Center5 years of reported clinical research
Studies Tumors
Studies Cancer
20 reported clinical trials
54 drugs studied
Kari B. WisinskiUniversity of Wisconsin Carbone Cancer Center6 years of reported clinical research
Expert in Breast Cancer
Studies Cancer
17 reported clinical trials
49 drugs studied
Ticiana A. LealUniversity of Wisconsin Hospital and Clinics4 years of reported clinical research
Expert in Non-Small Cell Lung Cancer
Expert in Lung Cancer
16 reported clinical trials
23 drugs studied
Clinical Trials running at University of Wisconsin
Multiple Myeloma
Plasma Cell Neoplasms
Lung Cancer
Stroke
Breast Cancer
Multiple Sclerosis
Kidney Stones
Pulmonary Fibrosis
Parkinson's Disease
Cancer
DVRd + Ciltacabtagene Autoleucel / ASCT
for Multiple Myeloma
The purpose of this study is to compare the efficacy of Daratumumab, Bortezomib, Lenalidomide and Dexamethasone (DVRd) followed by Ciltacabtagene Autoleucel versus Daratumumab, Bortezomib, Lenalidomide and Dexamethasone (DVRd) followed by Autologous Stem Cell Transplant (ASCT) in newly diagnosed multiple myeloma patients.
Recruiting4 awards Phase 34 criteria
Iberdomide Combo
for Multiple Myeloma
Similar to the paradigm established in other hematologic malignancies that are considered curable, the achievement of MRD(-) status is necessary for long term disease control in MM. The fact that the majority of patients remain MRD (+) after induction therapy and AHCT points to the opportunity to deploy novel agents with complementary mechanism of action and favorable toxicity profile to reach and maintain MRD (-) status. Given its favorable toxicity profile, the convenience of oral administration, and compelling single agent activity even in heavily pretreated MM, iberdomide is likely amenable to long term therapy in patients with high-risk of relapse/progression identified by the persistence of MRD(+). The investigators intend to develop combination(s) of iberdomide with other agents with complementary mechanism of action in the consolidation setting post AHCT in order to achieve and sustain MRD (-).
Recruiting3 awards Phase 1 & 214 criteria
Iberdomide vs Lenalidomide
for Multiple Myeloma
The purpose of this study is to compare the effectiveness of iberdomide maintenance to lenalidomide maintenance therapy after autologous stem cell transplantation (ASCT) in participants with newly diagnosed multiple myeloma (NDMM).
Recruiting2 awards Phase 3
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at University of Wisconsin?
University of Wisconsin is a medical facility located in Madison, Wisconsin. This center is recognized for care of Cancer, Recurrence, Breast Cancer, Tumors, Lung Cancer and other specialties. University of Wisconsin is involved with conducting 952 clinical trials across 1,471 conditions. There are 127 research doctors associated with this hospital, such as Kenneth B. De Santes, Nataliya V. Uboha, Kari B. Wisinski, and Ticiana A. Leal.
Where is University of Wisconsin located?
The University of Wisconsin Hospital is located at 600 Highland Ave, Madison, WI 53792.
Who should I call to ask about financial aid or insurance network?
For financial assistance and insurance inquiries at the University of Wisconsin Hospital:
- Contact UW–Madison Student Financial Services at 608-262-3060 or finaid@finaid.wisc.edu for general inquiries.
- For billing and insurance concerns, reach out to UW Medicine Patient Accounts and Support Services at 206.520.0400.
- UW Medicine provides financial assistance for patients meeting needs-based requirements for medically necessary care.
What insurance does University of Wisconsin accept?
The University of Wisconsin mandates the Student Health Insurance Plan (SHIP) for its students, scholars, visiting scientists, professors, postdoctoral fellows, and J-1 visa holders not registered for classes. SHIP provides comprehensive coverage including travel, vaccines, emergency services, and specialized medical care nationwide, with low cost-sharing for members. It is mandatory for international students and scholars, with premiums eligible for inclusion in the UW–Madison Financial Aid package for qualifying undergraduates.
What awards or recognition has University of Wisconsin received?
The University of Wisconsin Hospital, located in Madison, Wisconsin, is renowned for its excellence in research and patient care, especially in hospital medicine. It boasts a strong internal infrastructure and maintains partnerships with the UW School of Medicine and Public Health and UW-Madison. Additionally, UW Health, encompassing the University of Wisconsin Hospital, has been ranked as the number one hospital in Wisconsin for 12 consecutive years by U.S. News & World Report.